Jenny Kobin | Investor Relations |
George Lasezkay | Chief Executive Officer |
Thomas Ciulla | Chief Medical Officer and Chief Development Officer |
Charlie Deignan | Chief Financial Officer |
Zegbeh Jallah | ROTH Capital Partners |
Annabel Samimy | Stifel |
Andreas Argyrides | Wedbush Securities |
Yi Chen | H.C. Wainwright |
Jon Wolleben | JMP Securities |
Serge Belanger | Needham & Company |
Good day everyone and thank you for standing by. Welcome to the Clearside Biomedical Second Quarter of 2021 Financial Results and Corporate Update Call. At this time, all participants are in a listen-only mode. [Operator Instructions] And please be advised that today’s conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms.